课题基金 / 基金详情

项目摘要

项目成果

Jae-Wook Jeong的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): According to the CDC, 6% of married women between the ages of 15-44 are infertile, and 12.1% of women display difficulties getting pregnant or carrying a pregnancy to term. The loss of pregnancy before 20 weeks is called early pregnancy loss or miscarriage. They occur in about 15% of known pregnancies. Implantation defects contribute to over 75% of failed pregnancies, suggesting a need to focus research efforts towards understanding the complex mechanisms necessary for uterine receptivity and successful implantation. AT-rich interactive domain-containing protein 1A (ARID1A) is a member of the SWI/SNF family and is required for transcriptional activation of genes normally repressed by chromatin. ARID1A loss is a frequent event in endometrial cancers and endometriosis-associated ovarian carcinomas. However, an understanding of the pathophysiological effects of ARID1A mutations remains quite poor and the function of ARID1A in the female reproductive track has remained elusive. In our studies, ARID1A loss is implicated in infertile women with endometriosis. Furthermore, uterine-specific Arid1a knock-out mice were sterile due to a defect of implantation and decidualization. E2 signaling and proliferation of epithelium were significantly increased at the peri-implantation period of the mutant mice. The levels of epithelial PGR and its target genes are downregulated in mutant mice. On the basis of all these data, we hypothesized that ARID1A plays an important role for implantation and decidualization by suppressing ESR1 activities and enhancing PGR activities. An innovative therapeutic strategy would be to conduct preclinical studies designed to block aberrant epithelial proliferation and overcome impaired decidualization in infertility using mouse animal models as well as human endometriosis samples.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer
  • 批准号:
    10560609
  • 项目类别:
  • 资助金额:
    $54.09万
  • 财政年份:
    2022
  • 负责人:
    Jae-Wook Jeong
  • 依托单位:
Molecular mechanisms of endometrial progesterone resistance
  • 批准号:
    10618181
  • 项目类别:
  • 资助金额:
    $51.47万
  • 财政年份:
    2022
  • 负责人:
    Jae-Wook Jeong
  • 依托单位:
Development of anti-inflammatory nanodrug for endometriosis treatment
  • 批准号:
    10709492
  • 项目类别:
  • 资助金额:
    $62.86万
  • 财政年份:
    2022
  • 负责人:
    Jae-Wook Jeong
  • 依托单位:
The role of cholesterol biosynthesis in metastatic and recurrent endometrial cancer
  • 批准号:
    10467152
  • 项目类别:
  • 资助金额:
    $25.49万
  • 财政年份:
    2022
  • 负责人:
    Jae-Wook Jeong
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: